- Home
- UNCY vs OPRX Comparison
UNCY vs OPRX Comparison
Compare UNCY & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNCY | OPRX |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.3M | 117.1M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | UNCY | OPRX |
|---|---|---|
| Price | $5.07 | $7.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $25.67 | $16.67 |
| AVG Volume (30 Days) | ★ 832.9K | 206.2K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | $675,000.00 | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | $582.86 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $3.72 | $4.54 |
| 52 Week High | $8.74 | $22.25 |
Technical Indicators
Market Signals| Indicator | UNCY | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 60.10 |
| Support Level | $4.81 | $5.80 |
| Resistance Level | $5.39 | $7.03 |
| Average True Range (ATR) | 0.31 | 0.28 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 29.31 | 79.69 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.